Authors


Haiyan Qu, PhD

Latest:

Association of Part D Coverage Gap With COPD Medication Adherence

Using longitudinal Medicare claims data, this study quantified the association of the Medicare Part D coverage gap with medication adherence among beneficiaries with chronic obstructive pulmonary disease.


Chuhe Chen, PhD

Latest:

Factors Affecting Medication Adherence Trajectories for Patients With Heart Failure

Nonwhite race, smoking, and increasing body mass index were associated with the lowest adherence trajectories for patients with heart failure, with adherence dropping off within the first year.


Jeffrey G. Jarvik, MD, MPH

Latest:

It Is Time to Ask Patients What Outcomes Are Important to Them

Patients with abdominal or back pain identified 21 outcomes important to them, but the reported outcomes are quite different from the symptom and function outcomes studied by researchers.


Lauren K. Joarnt

Latest:

Potential Benefits of Increased Access to Doula Support During Childbirth

Increasing access to continuous labor support from a birth doula may facilitate decreases in non-indicated cesarean rates among women who desire doula care.


Steve J. Meurer, PhD, MBA, MHS

Latest:

Empirical Analysis of Domestic Medical Travel for Elective Cardiovascular Procedures

Promoting domestic medical travel to high-quality providers could improve clinical outcomes and reduce long-term healthcare costs.


Jeffrey L. Solomon, PhD

Latest:

How Do Providers Prioritize Prevention? A Qualitative Study

Primary care providers utilize many strategies for prioritizing preventive care during time-constrained clinical encounters, in addition to being prompted by clinical reminders.


Taruja D. Karmarkar, MHS

Latest:

Sofosbuvir Initial Therapy Abandonment and Manufacturer Coupons in a Commercially Insured Population

Member cost negatively affects initial medication adherence and manufacturer coupons can decrease member share by up to 98%.


Based on a presentation by Starlin Haydon-Greatting, MS, BSPharm, FAPhA

Latest:

The Role of the Pharmacist as Diabetes Caregiver

During her presentation, Haydon-Greatting who has trained as a pharmacist, talked about the influential role that a pharmacist could play in patient care and disease management.


Brian R. Edlin, MD

Latest:

Value of Expanding HCV Screening and Treatment Policies in the United States

Expanding screening for hepatitis C virus infection may generate substantial benefits for patients and society, but only when paired with expanded treatment policies.


Scott I. Mader, MD

Latest:

Substitutive Hospital at Home for Older Persons: Effects on Costs

Substitutive Hospital at Home care for 4 common conditions is associated with cost savings.


Paul A. Miner, PharmD

Latest:

Provider Organization Performance Assessment Utilizing Diabetes Physician Recognition Program

Retrospective chart review to assess the impact of the Diabetes Physician Recognition Program showed that most patients achieved control levels recommended by national treatment guidelines.


Vicky Gomez, MPH

Latest:

The FLU-FIT Program: An Effective Colorectal Cancer Screening Program for High Volume Flu Shot Clinics

Offering home fecal immunochemical tests to eligible patients during influenza vaccination clinic increases colorectal cancer screening rates.



Rosalie Malsberger, MS

Latest:

Examining Differential Performance of 3 Medical Home Recognition Programs

We examine utilization, quality, and expenditures among Medicare beneficiaries receiving care at federally qualified health centers and compare outcomes among those attributed to 1 of 3 recognition programs versus none.


Alan G. White, PhD

Latest:

Prescription Opioid Abuse: Challenges and Opportunities for Payers

This article outlines strategies insurers can use to mitigate their risks related to prescription opioid abuse by members, while addressing this serious public health problem.



Kirsten J. Axelsen, MS

Latest:

Medicare Part D Formulary Coverage Since Program Inception: Are Beneficiaries Choosing Wisely?

Analysis of Medicare Part D formulary composition since program inception suggests beneficiaries may not be using their open-enrollment periods to reevaluate available plan offerings.


Hadi Kharrazi, MD, PhD, MHI

Latest:

Assessing Markers From Ambulatory Laboratory Tests for Predicting High-Risk Patients

An evaluation of the added value of risk markers derived from ambulatory laboratory tests in the prediction of healthcare costs and identification of high-risk patients.


Sheldon Greenfield, MD

Latest:

Electronic Health Record Problem Lists: Accurate Enough for Risk Adjustment?

Electronic health record (EHR)-based comorbidity assessment had low sensitivity for identifying major comorbidities and poorly predicted survival. EHR-based comorbidity data require validation prior to application to risk adjustment.




Tara A. Lavelle, PhD

Latest:

Cost-Effectiveness of Collaborative Care for Depression and PTSD in Military Personnel

Centrally assisted collaborative telecare is a cost-effective strategy relative to usual care for treating posttraumatic stress disorder and depression in the Military Health System.


Bruce Y. Lee, MD, MBA

Latest:

Routine Pre-cesarean Staphylococcus aureus Screening and Decolonization: A Cost-Effectiveness Analysis

Routinely screening pregnant women for Staphylococcus aureus colonization and decolonizing carriers before cesarean delivery are unlikely to be cost-effective under current epidemiologic circumstances.



Bernard Kaminetsky, MD, FACP

Latest:

Personalized Preventive Care Leads to Significant Reductions in Hospital Utilization

We assessed the impact of the MDVIP personalized preventive care model on hospital utilization and found the MDVIP members' rates were substantially lower than nonmembers'.




John V. Pepper, PhD

Latest:

Dental Care Coverage Transitions

This study examines dental insurance transition dynamics in the context of changing employment and retirement status.


Jaime Rosenberg

Latest:

Amid Increasing Breast Implant–Related EBV+ DLBCL Cases, Researchers Share Insights on the Disease

Recognition of the association between breast implants and lymphomas has been notable since the 1990s, although the association has been limited to breast implant–associated anaplastic large cell lymphoma and not Epstein-Barr virus (EBV).


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo